...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Current opinion in gastroenterology >Probiotics in gastroenterology
【24h】

Probiotics in gastroenterology

机译：肠胃益生菌

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Recent evidence has suggested the potential therapeutic role for probiotics in the prevention or treatment of gastrointestinal diseases. Several studies have shown that probiotics are of benefit in gastrointestinal infections, including viral diarrhea, Clostridium difficile-associated diarrhea, traveler's diarrhea, and antibiotic-associated diarrhea. Recent data support the potential beneficial therapeutic effect in inflammatory bowel disease as well. Other possible indications for probiotic treatment include Helicobacter pylori infection, irritable bowel syndrome, and radiotherapy-associated diarrhea. It is important to select well-characterized preparations; in fact, the viability and survival of many available preparations are unproven. More precise information on the mechanisms by which probiotic strains exert their beneficial effects in vivo is needed. This may provide the scientific rationale for the selection of the best probiotic strains to use in the performance of large, double-blind, controlled clinical trials.
机译：最近的证据表明，益生菌在预防或治疗胃肠道疾病中具有潜在的治疗作用。数项研究表明，益生菌对胃肠道感染有益，包括病毒性腹泻，艰难梭菌相关性腹泻，旅行者腹泻和抗生素相关性腹泻。最近的数据也支持在炎症性肠病中潜在的有益治疗作用。益生菌治疗的其他可能适应症包括幽门螺杆菌感染，肠易激综合症和放疗相关的腹泻。选择特征明确的制剂很重要;实际上，许多可用制剂的生存力和存活率尚未得到证实。需要有关益生菌菌株在体内发挥有益作用的机制的更精确信息。这可以为选择最佳益生菌菌株以进行大型，双盲，对照临床试验提供科学依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号